Elevance Health
1,214 hedge funds and large institutions have $78.2B invested in Elevance Health in 2021 Q1 according to their latest regulatory filings, with 127 funds opening new positions, 436 increasing their positions, 441 reducing their positions, and 80 closing their positions.
65% more funds holding in top 10
Funds holding in top 10: 23 → 38 (+15)
59% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 80
12% more capital invested
Capital invested by funds: $69.9B → $78.2B (+$8.26B)
3% more funds holding
Funds holding: 1,173 → 1,214 (+41)
1.35% more ownership
Funds ownership: 88.64% → 89.99% (+1.3%)
1% less repeat investments, than reductions
Existing positions increased: 436 | Existing positions reduced: 441
16% less call options, than puts
Call options by funds: $588M | Put options by funds: $696M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
+$377M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$307M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$258M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$230M |
| 5 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$168M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$597M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$254M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$221M |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$167M |
| 5 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$166M |
ELV Hedge Fund Activity: Q1 2021 in Review
1,214 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2021, worth a combined $78.2B — up 12% from $69.9B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new ELV positions and 80 closed out — a net gain of 47 holders — while 436 added to existing stakes and 441 trimmed.
The largest buyer was Ruane, Cunniff & Goldfarb, opening a new position worth an estimated $377M. The largest seller was Fidelity Investments, cutting an estimated $597M.
- 1,214 institutional investors held Elevance Health (ELV) as of Q1 2021, up from 1,173 in Q4 2020.
- Funds reported $78.2B of Elevance Health stock for Q1 2021, up 12% quarter-over-quarter.
- 127 funds opened new Elevance Health positions in Q1 2021 and 80 closed out, a net change of +47 holders.
- The largest Elevance Health buyer in Q1 2021 was Ruane, Cunniff & Goldfarb, an estimated $377M added.
- The largest Elevance Health seller in Q1 2021 was Fidelity Investments, an estimated $597M sold.
Based on aggregated 13F filings for Q1 2021.